(Q39390484)

11 September 2017

title

Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression (English)

1 reference

11 September 2017

1 reference

Hiu-Fung Yuen

1

1 reference

11 September 2017

Cian M McCrudden

2

1 reference

11 September 2017

Claire Grills

3

1 reference

11 September 2017

Shu-Dong Zhang

4

1 reference

11 September 2017

Yu-Han Huang

5

1 reference

11 September 2017

Ka-Kui Chan

6

1 reference

11 September 2017

Yuen-Piu Chan

7

1 reference

11 September 2017

Michelle Lok-Yee Wong

8

1 reference

11 September 2017

Simon Law

9

1 reference

11 September 2017

Gopesh Srivastava

10

1 reference

11 September 2017

Dean A Fennell

11

1 reference

11 September 2017

Glenn Dickson

12

1 reference

11 September 2017

Mohamed El-Tanani

13

1 reference

11 September 2017

Kwok-Wah Chan

14

1 reference

11 September 2017

publication date

3 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

103

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

1145-1154

1 reference

Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

BMP antagonists: their roles in development and involvement in pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

The molecular pathogenesis of Barrett's esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

The prognostic significance of BMP-6 signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

A novel osteogenic helioxanthin-derivative acts in a BMP-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Differential regulation of steroidogenesis by bone morphogenetic proteins in granulosa cells: involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

PrognoScan: a new database for meta-analysis of the prognostic value of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic proteins and cancer: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Bone morphogenetic protein signalling in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

The disparate role of BMP in stem cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02252.X

Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition

21 January 2018

1 reference

12 December 2020

Bone morphogenetic protein expression patterns in human esophageal atresia with tracheoesophageal fistula

1 reference

12 December 2020

Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia

1 reference

12 December 2020

Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02252.X

Identifiers

DOI

1 reference

11 September 2017

0 references

1 reference